News & Events about Rafael Holdings Inc Class B.
Globe Newswire
7 months ago
Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc.(Cornerstone or the Company), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced a publication on preclinical data supporting CPI-613 (devimistat) targeting ...
Globe Newswire
8 months ago
Cranbury, NJ, May 24, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (Cornerstone or the Company), a company focused on rare cancer therapeutics and formerly known as Rafael Pharmaceuticals, today announced that the European Medicines Agency (EMA) has granted orphan drug designation to ...
Globe Newswire
8 months ago
Company name change reflects mission to address significant unmet needs in rare cancer therapeutics, returning to company rootsCranbury, NJ, May 19, 2022 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael or the Company), a company focused on the development of rare cancer therapeutics, today ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PR Newswire NEW YORK, March 26, 2022 NEW YORK, March 26, 2022 /PRNewswire...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rafael Holdings, Inc. - RFL PR Newswire NEW YORK, March 16, 2022 NEW YORK, March 16, 2022 /PRNewswire...